| Iris Neoplasm studied in …STUDIED_INderived17 of 17show fewer |
|---|
| → studied in | NCT01989572Phase 3 · completed Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628883Phase 1 · completed Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068586Phase 2 · active not recruiting Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03809585recruiting Observational Study of Iris Tumors · condition mapped ALIAS · 17 trials mapped (2 active) | — | — | Iris Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02336763NA · terminated Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413191Phase 2 · completed Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01100528Phase 2 · completed Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121225Phase 2 · completed Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243061Phase 2 · completed AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00406120withdrawn Validation of a Molecular Prognostic Test for Eye Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450255Phase 2 · completed VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01143402Phase 2 · completed Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730157early Phase 1 · terminated Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089063Phase 2 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00329641Phase 2 · completed Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085189Phase 2 · completed Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00288041Phase 2 · completed Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma · condition mapped ONTOLOGY_EXACT · 17 trials mapped (2 active) | — | — | Iris Melanoma | 1 | Observed | clinicaltrials | graph → |